Correction: Anti-CD3/CD7 Immunoconjugate (T-Guard) for Severe, Steroid-refractory GVHD: Final Report of BMT CTN 2002
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.